Interview: Mark Augusti, CEO @ Bioventus, the new Smith and Nephew Biologics spinout

Smith & Nephew Biologics new Joint Venture with Essex Woodlands – An Interview with Mark Augusti (OrthoSpineNews)
We recently heard the news about Smith & Nephew selling 51% of their Biologics division to Essex Woodlands in a Joint Venture. We caught up with the new President and CEO of the new company and got his thoughts on the news.
Interview with Mark Augusti, CEO Bioventus LLC.
Drue De Angelis: Mark, thanks for taking some time with us today. Could you give us your brief background and how did you end up where you are today? 
Mark Augusti:  I joined GE Medical Systems right out of...